Nifty Future R1: 7898 R2: 7940 R3: 8017
Pivot: 7822 S1: 7779 S2: 7703 S3: 7661
Chart Interpretation :-
Nifty spot close above the retracement breakout 7800. Next level in spot is 7950-8050.
Mechanical indicator stochastic and RSI also showing buying movement in nifty future.
Index Outlook :-
NIFTY FUTURE:-
Nifty extended gains for the fourth consecutive session on Thursday after the US Federal Reserve raised interest rates for the first time in nearly a decade and signalled its tightening cycle would be “gradual.” Sensex closed 309.40 points up at 25,803.78, while NSE Nifty settled 93.45 points up at 7,844.
INTRADAY STRATIGY:-
Buy Nifty above the range of 7850 for target of 7930-7980 stop loss: 7750.
Corporate News :-
Hindustan Unilever Ltd (HUL) has signed an agreement with Mosons Group to acquire its flagship brand Indulekha for Rs. 330 crore.
Aurobindo Pharma Ltd has announced that it has received final approval from the US Food & Drug Administrat- ion (USFDA) to manufacture and market Loperamide Hydrochloride Tablets, 2 mg.
Vivimed Labs said its board of directors would meet on 11 January 2016, to consider a stock-split proposal.
If you want to more information regarding the Nifty spot,nifty future,Stock tips & many other call @ 8109999233 or fill form http://equityresearchlab.com/Freetrial.php
Pivot: 7822 S1: 7779 S2: 7703 S3: 7661
Chart Interpretation :-
Nifty spot close above the retracement breakout 7800. Next level in spot is 7950-8050.
Mechanical indicator stochastic and RSI also showing buying movement in nifty future.
Index Outlook :-
NIFTY FUTURE:-
Nifty extended gains for the fourth consecutive session on Thursday after the US Federal Reserve raised interest rates for the first time in nearly a decade and signalled its tightening cycle would be “gradual.” Sensex closed 309.40 points up at 25,803.78, while NSE Nifty settled 93.45 points up at 7,844.
INTRADAY STRATIGY:-
Buy Nifty above the range of 7850 for target of 7930-7980 stop loss: 7750.
Hindustan Unilever Ltd (HUL) has signed an agreement with Mosons Group to acquire its flagship brand Indulekha for Rs. 330 crore.
Aurobindo Pharma Ltd has announced that it has received final approval from the US Food & Drug Administrat- ion (USFDA) to manufacture and market Loperamide Hydrochloride Tablets, 2 mg.
Vivimed Labs said its board of directors would meet on 11 January 2016, to consider a stock-split proposal.
If you want to more information regarding the Nifty spot,nifty future,Stock tips & many other call @ 8109999233 or fill form http://equityresearchlab.com/Freetrial.php
Your forecasting on share market conditions are accurate. If you Need more Commodity tips and news on share market, then join Epic research
ReplyDelete